Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $43

Author: Benzinga Newsdesk | October 14, 2025 08:33am

Keybanc analyst Austin Wurschmidt maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $40 to $43.

Posted In: AHR